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FORUM REVIEW ARTICLE
The Reactive Species Interactome:
Evolutionary Emergence, Biological Significance,
and Opportunities for Redox Metabolomics
and Personalized Medicine
Miriam M. Cortese-Krott,1 Anne Koning,2 Gunter G.C. Kuhnle,3 Peter Nagy,4 Christopher L. Bianco,5
Andreas Pasch,6 David A. Wink,7 Jon M. Fukuto,8 Alan A. Jackson,9 Harry van Goor,2
Kenneth R. Olson,10 and Martin Feelisch9,11
Abstract
Significance: Oxidative stress is thought to account for aberrant redox homeostasis and contribute to aging and
disease. However, more often than not, administration of antioxidants is ineffective, suggesting that our current
understanding of the underlying regulatory processes is incomplete.
Recent Advances: Similar to reactive oxygen species and reactive nitrogen species, reactive sulfur species are
now emerging as important signaling molecules, targeting regulatory cysteine redox switches in proteins, af-
fecting gene regulation, ion transport, intermediary metabolism, and mitochondrial function. To rationalize the
complexity of chemical interactions of reactive species with themselves and their targets and help define their role
in systemic metabolic control, we here introduce a novel integrative concept defined as the reactive species
interactome (RSI). The RSI is a primeval multilevel redox regulatory system whose architecture, together with the
physicochemical characteristics of its constituents, allows efficient sensing and rapid adaptation to environmental
changes and various other stressors to enhance fitness and resilience at the local and whole-organism level.
Critical Issues: To better characterize the RSI-related processes that determine fluxes through specific pathways
and enable integration, it is necessary to disentangle the chemical biology and activity of reactive species
(including precursors and reaction products), their targets, communication systems, and effects on cellular,
organ, and whole-organism bioenergetics using system-level/network analyses.
Future Directions: Understanding the mechanisms through which the RSI operates will enable a better appre-
ciation of the possibilities to modulate the entire biological system; moreover, unveiling molecular signatures that
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characterize specific environmental challenges or other forms of stress will provide new prevention/intervention
opportunities for personalized medicine. Antioxid. Redox Signal. 27, 684–712.
Keywords: hydrogen sulfide, polysulfides, nitric oxide, systems biology, microbiome, network medicine
Introduction
Nothing in biology makes sense except in the light of evolution.
—Theodosius Dobzhansky
Life is nothing but an electron looking for a place to rest.
—Albert Szent-Gyo¨rgyi
We are witnessing an unprecedented paradigmaticchange in the practice of medicine whereby the concept
of intervention is evolving from treatingdiseases in a one-organ/
one-symptom manner to a systems-based approach that con-
siders a patient’s pathophysiological condition, including his/
her individual genetic blueprint, microbiome, disease history,
and lifestyle. Indeed, diseases presenting with similar clinical
phenotypes are oftenheterogeneous conditions ofmultifactorial
origin, involving a multitude of molecular, cellular, and organ
systems. Their multilevel nature and complexity pose a formi-
dable challenge to identifying themolecular causes; finding the
most suitable therapy for each specific case demands a thorough
understanding of the fundamental principles of biological reg-
ulation and a refined interdisciplinary systems approach en-
compassing medicine, pharmacology, biology, chemistry, and
physics. Recent analyses indicate the existence of disease-
specific functional modules that are central hubs in the vast
network of human diseases, offering additional opportunities by
embracing mathematical approaches.
A limited number of risk factors (such as poor quality nu-
trition or physical inactivity) and chronic conditions (including
hypertension, cardiovascular disease, obesity, asthma, diabe-
tes, neurodegenerative diseases, and certain forms of cancer)
account for the majority of the global burden of disease (114),
overall life expectancy, and all-cause mortality (203). A
common feature ofmany of these conditions is oxidative stress
(176), and some have been redefined as redox diseases (26,
206). The term oxidative stress was originally described as an
imbalance between oxidants and antioxidants in favor of the
oxidants, leading to a disruption of redox signaling and control
and/or molecular damage (91, 174); it was initially considered
to be triggered by an inflammatory process or mitochondrial
dysfunction. However, the use of selective antioxidants for
redox diseases has not had the effect anticipated, suggesting
that our current understanding of the underlying pathophysi-
ological processes is incomplete (26, 176).
Recently, Jones and Sies proposed that besides the Genetic
Code, allowing reproduction and defining heredity, there
exists a Redox Codei that identifies the regulatory elements
and defines the principles through which biological function
is enabled and protected (94). Within this concept, the en-
dogenous production of reactive oxygen species (ROS) is a
highly regulated enzymatic process, which serves the pur-
pose of signaling and can lead to modification of cysteine
redox switches. Modification of these switches leads to
modulation of their functional state, which would result in
alterations of protein structure, enzymatic activity, or gene
transcription. Modifying responses to match a changed en-
vironment creates the opportunity for adaptive changes that
enhance an organism’s fitness for purpose.
However, there is more to this redox network than ROS.
Nitric oxide (NO) is a free radical, which is produced en-
dogenously by NO synthases (NOS) and acts as an effector
and messenger, regulating a variety of physiological pro-
cesses. Chemical interactions of NO with ROS form reactive
nitrogen species (RNS) and constitute the basis for the for-
mation of a multitude of additional oxidative signaling ele-
ments (65), including the highly reactive and potentially
damaging peroxynitrite (ONOO-). Both ROS and RNS may
target cysteine thiols leading to oxidative modifications (in-
cluding formation of sulfinic acid, sulfenic acids, thiyl radi-
cals, and sulfane sulfur-containing molecules, such as
persulfides and polysulfides) (131, 132, 140). By analogy to
ROS and RNS, these compounds are identified as reactive
sulfur species (RSS) (67). Similar to ROS and RNS, RSS
were first considered to be produced only under pathological
conditions and not recognized as being involved in signaling
functions. More recently, hydrogen sulfide (H2S) and its
sulfane sulfur derivatives have been shown to participate in
fundamental biochemical pathways that control cellular re-
dox homeostasis, signaling, metabolism, and mitochondrial
function (145, 204); this is perhaps most intriguingly illus-
trated by the phenomenon of suspended animation observed
after H2S inhalation in small rodents (11). These observations
have led to a renewed interest in sulfide chemistry and bi-
ology (37, 38, 104, 126, 187) and RSS, together with ROS
and RNS, to be considered as important physiological sig-
naling molecules.
The view that placed oxygen at the center of the redox
regulatory system has been questioned recently by the reali-
zation that much of the evolutionary biology of life evolved in a
sulfur-rich atmosphere virtually free of oxygen (135, 139).
Indeed, it is considered likely that the interaction of RSS with
RNS to form S/N-hybrid species participated in forming the
building blocks of life and preceded the advent of aerobic
respiration and ROS formation (41). In this model, as the
level of atmospheric oxygen rose, enabling the development of
iIn this context, the word ‘‘code’’ is used to describe a set of
principles, rather than a carrier of information like in the genetic
code.






















































larger and more energy-efficient organisms, the ancient
mechanisms of sulfur metabolism had to face the new chal-
lenge of dealing with rapid oxidation processes superimposed
onto those that controlled electron transfer in all life forms until
then. This model helps to explain why many regulatory path-
ways are connected to fundamental sulfur-mediated electron
transfer processes. As the levels of complexity increased from
unicellular to larger multicellular organisms, the fundamental
principles of regulation were conserved.
In this review, we provide an integrative biology concept
of redox regulation (Fig. 1). We here define the chemical
interaction of RSS, RNS, and ROS among themselves and
with downstream biological targets as the reactive species
interactome (RSI) (Box 1; Table 1). We propose that the RSI
serves an integrative function to sense multiple stressors and
adjust bioenergetic/metabolic needs accordingly by activat-
ing downstream effector pathways to ensure the organism is
able to respond to environmental change and stay fit for
purpose (Box 2 and Fig. 1). Within this model, H2S along
with other thiols is considered an important source of RSS,
which have a critical role in enabling and supporting this
complex cell signaling network.
The current review discusses how (i) the RSI evolved and
contributed to shape evolution; (ii) the chemistry of the RSI is
linked to cysteine-based redox switches/relays, enabling
sensing and transduction of stress signaling for short- and
long-term adaptation; (iii) precursor/cofactor availabilities
due to changes in intermediary metabolism affect the RSI;
(iv) a system-level analysis of these redox signaling elements
can contribute to our understanding of fundamental biology
and (patho)physiology; and how (v) embracing redox biology
in clinical practice and public health can help explain vari-
ability in response and thereby contribute to the development
of more appropriate sensitive and specific and preventive or
therapeutic interventions.
How It All Began: Evolution of the RSI
Life began nearly 4 billion years ago (bya), and*85% of
all ensuing evolution occurred under anoxic or extremely
FIG. 1. Intracellular, extracellular, and interorgan/systemic role of the RSI. Precursors of the RSI are organic and
inorganic substrates and cofactors, including amino acids (e.g., arginine, methionine), vitamins (B6, B12, C), and xanthine,
as well as oxygen, nitrite, polysulfides, thiosulfate, and sulfate, which are transformed by mitochondrial or cytoplasmic
enzymes into ROS, RNS, and RSS. The chemical interactions among ROS, RNS, and RSS lead to formation of a number of
products with different reactivities, stabilities, half-lives, and therefore different lifetimes defined by their physicochemical
properties, covering a wide range of maximal travel distances. A common target of the RSI are cysteine thiols in proteins,
acting as redox switches, able to fine-tune activity of signaling molecules, and leading to short-term responses (e.g., protein
kinases and phosphatases inducing changes in signaling and glucose metabolism) or long-term adaptation (by modifying
redox switches responsible for gene expression regulation, such as the HIF, NFkB, and Keap1/Nrf2 pathways). The RSI
serves also as a local and systemic heterocellular communication system mediated by actions of longer-lasting products of
the RSI (e.g., nitrite, polysulfides) and circulating thiols. The nutritional and physiological status of the organism affects the
RSI by reciprocally regulating precursor availability, metabolism, signaling, and mitochondrial function. RNS, reactive
nitrogen species; ROS, reactive oxygen species; RSS, reactive sulfur species.






















































hypoxic conditions. Rather than oxygen, two other gases,
H2S and NO, were present in the early atmosphere and ar-
guably shaped the bulk of the evolution of life on Earth.
Two decades ago, a case was made that NO production
by simple life forms may have provided a crucial survival
mechanism against ROS at the time of emergence of aerobic
life, offering an opportunity for its further utilization as an early
signaling molecule (56). Intriguingly, the story of reactive
species may have started much earlier. Indeed, more recently,
H2S has been implicated in the origin of life (139). The fol-
lowing section places emphasis on the role of sulfur in the
evolution of redox metabolic systems; how, at a later stage, O2
replaced some of the roles of sulfur as donor and acceptor of
electrons for energy metabolism and signaling; and how reac-
tive species may have contributed to the evolution of life by
enabling environmental sensing, metabolic plasticity, and cell–
cell communication. Comparisons with other life origin theo-
ries, for example, the hydrogen hypothesis, the RNAworld, and
panspermia, are beyond the scope of this article. For a more
comprehensive treatise of how the emerging field of systems
chemistry has shaped our understanding of the origin of life and
that of metabolism and the fundamentals of biochemical ad-
aptation, the reader is referred elsewhere (20, 80, 149).
Prebiotic primordial interactions: generating
the building blocks of life
Life requires a set of essential molecular building blocks
from which to assemble more complex structures, enzymes
to direct these processes, membranes to partition simulta-
neously occurring events, and energy to overcome inherent
entropies (Box 3). The building blocks of life comprise in-
organic or organic precursors of RNA, DNA, and proteins.
These were proposed to be derived from (i) intense electrical
discharge in a primordial soup containing basic elements,
such as carbon, sulfur, and nitrogen (125); (ii) atmospheric
photochemical reactions (158); (iii) through volcanic activity
and hydrothermal fissures in the Earth’s crust; and (iv) ex-
traterrestrial sources ranging from collisions with massive
objects (22, 147) to the fine interstellar dust, which continues
to add a large amount of organic compounds to Earth on a
daily basis (9). However, as only volcanic activity can pro-
vide a constant and reliable source of energy, it is most likely
that life emerged here (98, 148).
The Earth’s earliest atmosphere must have contained large
amounts of H2S (198). Sulfide is an efficient reductant and its
chemical nature was fundamental for driving protometabolic
reactions with N2 and CO2 to form RNA, amino acids, and
lipid precursors (142). Our planet has been likened to a pri-
mordial reaction cell (148) where energy in the form of re-
ducing equivalents, namely ferrous iron (Fe2+) and sulfide
(H2S, HS
-, S2-), traversed the Earth’s crust through pores
(hydrothermal vents) at a steady and therefore dependable
rate. Many of these hydrothermal vents sit on massive sulfide
deposits called sulfide lenses (168, 169), where the magmatic
flow heats the water to over 400C. The combination of heat,
water, and high pressure drives organic synthesis not possible
under other conditions, and as the water rises and cools, the
products become stable.
An argument can be made for the primacy of sulfide in the
origin of life: in combination with transition metals, especially
iron, copper, zinc, molybdenum, and tungsten, allowing one-
and two-electron transitions, sulfides formed a variety of cat-
alysts that were prototypical enzymes for organic synthesis
and created a platform upon which synthesis could occur (33,
163, 200, 201). These metal sulfide minerals formed primor-
dial membranes, allowing compartmentalization of parallel
chemical reactions (122). Then, the constant flux of reducing
equivalents into the comparatively oxidizing environment of
seawater provided a continually renewed and reliable energy
source. In addition, some oxidized sulfur coming from the
vents gave rise to the formation of defined redox zones.
Evolution of life: from sulfur to oxygen
Life is likely to have begun around hydrothermal vents in a
ferrungious (anoxic and Fe2+ rich) ocean *3.8 bya (153,
164) and it was chemolithotrophic, completely dependent
upon the Earth for energy (Fig. 2). Within a surprisingly short
time, 200–400 million years, photosynthesis appeared, which
allowed life to become independent from Earth’s energy. The
earliest light-gathering antennae were not able to harvest
enough light to oxidize water and the process was anoxy-
genic. It has been proposed that an intermediate such as H2O2
Box 1. The Reactive Species Interactome
The reactive species interactome (RSI) is a redox system consisting of chemical interactions of RSS, RNS, and ROS
among themselves and with downstream biological targets.
The RSI is characterized by (i) robustness and flexibility; (ii) adaptability; (iii) rapid responsiveness; (iv) ability to sense
the environment; and (v) the ability to transduce signals that are required for fine-tuning of biological functions and
communication at multiple levels.
The richness of chemical products of the RSI affords the unique redundancy and flexibility of the system. The products of
the RSI are continually generated by enzymatic reactions and are as varied as the chemistries of the reactive species
themselves. Chemical interactions of the RSI include one- and two-electron oxidation, nitrosation, nitration, and sul-
furation/polysulfidation reactions. Each of the species of this interactome has a distinct reactivity and lifetime that are
defined by its physicochemical properties (65) and by environmental conditions (such as temperature, pH, and pO2),
covering a wide range of maximal travel distances and thus action radii (35, 79, 215).
Being a product of regulated enzymatic transformation of nutrients (amino acids and inorganic substrates such as nitrite
and sulfate), the RSI allows rapid adjustment to changes in environmental conditions (e.g., by post-translational modifi-
cations) as well as long-term adaptation by regulation of gene expression. It thereby serves an integrative function to sense
and transduce multiple stressors, adjust bioenergetic/metabolic needs, and activate downstream effector pathways to
ensure the organism stays fit for purpose.






















































Table 1. Definition of Terms
Term Definition References
Stress and adaptation
Stress/adaptation to stress The term stress, as used in biomedical literature, was coined by
Hans Selye in the 1930s, who defined it as ‘the nonspecific
response of the body to any demand for change’
(166)
Cellular stress response A set of cellular responses (including the downregulation of
protein synthesis and upregulation of transcription factors
involved in defense and repair mechanisms) common to all
eukaryotes aimed at coping with various forms of stress; also
known as ‘integrated stress response’
(141, 150)
Hormesis Beneficial effects of low levels of stress (‘‘what does not kill us
makes us stronger’’)
(121)
Redox chemistry and biology
Oxidative stress An imbalance between oxidants and antioxidants in favor of the
oxidants, leading to a disruption of redox signaling and control
and/or molecular damage
(176)
Reactive species Compounds with high chemical reactivity produced enzymatically
or nonenzymatically; the interaction of reactive species may
produce other reactive species
(73)
Reactive oxygen species (ROS) Chemically reactive compounds derived from oxygen
Reactive nitrogen species (RNS) Chemically reactive compounds originating from the reaction of
nitric oxide with oxygen or oxygen-derived compounds
Reactive sulfur species (RSS) According to Jacobs et al. produced by toxification of thiols by
reactive oxygen and nitrogen species, including disulfide-S-
oxides, sulfenic acids, and thiyl radicals, and predicted to
modulate the redox status of biological thiols and disulfides;
more recently, RSS were discussed as putative regulatory




Chemical interaction of RSS, RNS, and ROS (possibly including
other short-lived species to be discovered in the future) among
themselves and with downstream biological targets. The RSI is
characterized by (i) high variability/adaptability; (ii) rapid
responsiveness; (iii) flexibility, which is required for fine-tuning
of biological functions and communication at multiple levels;
and (iv) high redundancy (explaining why antioxidants do not
work)
This review
Redox regulation A term used to define the control of redox signaling (176)
Redox code A set of principles that defines the positioning of the nicotinamide
adenine dinucleotide (NAD, NADP), thiol/disulfide, and other
redox systems, as well as the thiol redox proteome in space and
time in biological systems
(94)
Personalized and redox medicine
Redox switches/protein thiol
switches
Protein thiols that are specifically and reversibly modified by
oxidation, thereby switching the protein between different
conformational and functional states
(15,70)
Personalized medicine Healthcare that is tailored to individual condition, needs, and
lifestyle (in contrast to one size fits all approach)
Precision medicine Healthcare that is tailored to the basis of an individual’s genes,
lifestyle, and environment
(81)
Stratified medicine A therapy that is targeted to a specific patient population on the
basis of a clinical characteristic such as a biomarker that
predicts treatment response
(194)
Redox medicine/redox diseases Diseases with involvement of aberrant redox regulation/processes
ranging from oxidative to reductive stress
(26, 206)
P4 medicine Predictive, personalized, preventive, and participatory (P4) med-
icine. P4 medicine is fueled by systems approaches to disease,
emerging technologies, and analytical tools
(84)
Developmental origins of health
and disease
A paradigm affirming that environmental influences experienced
during early embryonic development may influence the risk of
noncommunicable diseases later in life and across generations
(77)
The table defines the scientific terms used in the Review; the defined terms were marked in italics in the main text.
RNS, reactive nitrogen species; ROS, reactive oxygen species; RSI, reactive species interactome; RSS, reactive sulfur species.






















































Box 2. The Reactive Species Interactome in Sensing, Signaling, and Adaptation to Stress:
Principles of Regulation in the Context of Origins of life, Evolution, and Adaptation
Organisms observed today represent a snapshot of now—that is, a cross-sectional view encompassing historical ex-
perience of preferred life forms that survived past evolutionary stresses, are compatible with the prevailing environment,
and fit for purpose. Assuming the overarching biological purpose is reproduction, this requires faithful replication of
complex structures and molecular forms, which need to be dynamic yet sufficiently stable to assure structural and
functional integrity of the system as a whole.
Biological flexibility in response provides resilience to all sorts of stressors in a constantly changing environment and
can be identified at all levels of organization, which can be rationalized in terms of mathematics (networks), (bio)physical,
(bio)chemical, and physiological principles, as well as individual behavior and function, group behavior, and social
realities on a global scale.
Influenced by Claude Bernard’s concept of the milieu interieure and Walter Cannon’s notion of homeostasis, the term
stress was coined by Hans Selye in the middle of the last century; using experimental animal models, Selye also observed
that persistent stress could lead to the development of various diseases (166). Mechanisms enabling to cope with stress are
crucial checkpoints for resilience. Adaptation to (perceived or real) environmental, nutritional, lifestyle-related, or mental
stresses serves the purpose to improve the fitness of a biological organism to deal with those stresses in the future. The
concept of hormesis describes the ability of small stresses to confer protection via activation of the cellular stress response
(121), a universal defense reaction of cells to damage to cellular macromolecules (107).
Providing biological flexibility requires energy, which is derived from the release of chemical energy in food to produce
heat, readily available forms of energy (e.g., ATP, creatine phosphate), and reducing equivalents [NAD(P)H]; reacting to
specific shortages in energy supply requires metabolic plasticity; and adjusting metabolism appropriate to the prevailing
conditions requires a sensing and adaptation system. Resilience against stress also demands coupling of the sensing
elements to appropriate protection and repair systems that provide a first line of defense (in the form of e.g., antioxidants/
antioxidant enzymes) and a system that can identify, repair, or excise damage to biomolecules or tissues caused by
endogenous reactive species or exogenous toxicants. Thus, effective buffering against potentially harmful conditions and/
or environmental threats requires all four: sensing, adaptation, defense, and repair systems working in concert to confer
protection, offer stability, and offset damage. The RSI is involved in sensing/utilizing available energy resources as
efficiently as possible by coordinating a system of complex interwoven pathways that ensure smooth operation while
allocating sufficient energy for protection and repair of damage to DNA and other critical cell constituents by environ-
mental stressors. Compromised bioenergetic status comes at the price of increased vulnerability to environmental threats.
Box 3. Fundamental Principles Underpinning Molecular Interactions in Biology
1. Chemical principles
Inorganic interactions. The characteristic aqueous environment and energy (in the form of heat) create conditions
wherein random interactions lead to the formation of reactive chemicals, based upon the physicochemical characteristics of
the atoms/elements (including S, N, O) they contain, prevailing in gaseous and ionic form, and as solutes.
Transition metal chemistry. Transition metals play a special role in catalysis, Fenton reactions, protection against free
radicals, redox status (Fe, Mg, Zn, Cu, W, Tn), and display a highly protected/compartmentalized metabolism.
2. Biophysical principles
Organic compounds formed at some stage from carbon and hydrogen, allowing to form alkane/alkene (CH) chains;
oxygen enabled carbohydrate (CHO) and fatty acids formation, whereas N and S enabled amino acid and protein formation
with special structural characteristics whereas lipids enable boundary formation and compartmentalization.
The bilayer structure of membranes is dependent upon physical rearrangement of the chains according to their lipo-
philicity / hydrophilicity, i.e. based on physicochemical properties.
3. Biological ordering principles
Compartmentalization enabled cellular and sub-cellular activities, mitochondria increased energetic efficiency, and
protein and CHO buffering capacity to bring some stability to the internal environment (physical, pH, redox), with
preferential reactions, structured in both space and time.
4. Bioenergetic principles
All reactions have positive and negative consequences. The goal is to achieve a balance of these to support and enable a
suitable structure that enables function – ongoing iteration serves to refine both structure and function to make the organism
more fit for purpose and better fit for the current environment, its challenges and opportunities.
All processes aimed at counteracting entropy are energetically costly, and a sensible balance must be struck between
costs of living and repair. Under stress, repair processes are placed ‘on hold’ until the acute situation is under control;
processes impairing mitochondrial activity more chronically have the potential to lead to cellular bioenergetic failure,
accumulation of damage and ultimate system failure.






















































was used as the initial electron donor (154). However, H2O2
would have been in short supply, and it is more likely to have
been H2S, H2S2, or a related sulfur species (Eq. 1), as seen in
modern-day green and purple sulfur bacteria (62).
H2SþCO2þ hv ! SnþCH4 [1]
This reaction is important because H2S was plentiful and
the enzymes that evolved to catalyze this reaction could be
readily adapted to oxidize H2O once sufficient energy could
be extracted from the sun.
Oxygenic photosynthesis likely first appeared in cyano-
bacteria around 3 bya (Fig. 2). This ultimately led to the great
oxidation event around 2.3 bya when atmospheric O2 is
thought to have risen to 1%–2%, which is 5%–10% of present
atmospheric levels (45, 164). However, apart from small
oxygen oases in the shallows, the oceans remained anoxic.
Although limited, atmospheric O2 slowly oxidized exposed
elemental sulfur and dissolved H2S/HS
- to sulfate, which was
then carried to the oceans, reduced to H2S by the pervasive
Fe2+, and within a hundred million years, vast areas of ocean
became euxinic (anoxic and sulfidic). It was in this envi-
ronment that endosymbiosis, in which a sulfur-reducing
Archaea engulfed a sulfide-oxidizing a-protobacterium,
produced the mitochondrion around 1.5 bya (111, 165).
These early eukaryotes would later incorporate cyano-
bacteria and thus become the ancestors of modern-day
plants. Combined oxygen production by cyanobacteria
and primitive plants eventually oxidized all the oceanic iron
and sulfide, and around 600 million years ago, atmospheric
O2 began to increase to present-day levels (Fig. 2). This
oxic environment is generally thought to have had dire
consequences due to formation of hydroxyl radicals (HO),
H2O2, and superoxide (O2
-), collectively defined as ROS,
(Eq. 2);
H2O( e )! HO ! H2O2 ( e )
! O2 ( e )! O2
[2]
According to the OxTox hypothesis, organisms had to
develop antioxidant strategies (109), retreat to anoxic niches,
or die. However, was it really this bad?
Antioxidant defense or rather sulfur
detoxifying strategies?
Before the atmosphere enriched with O2, it is quite likely
that the early anoxygenic photosynthesis (Eq. 3) initially
evolved as stepwise one-electron oxidation of H2S (Eq. 3);
FIG. 2. Evolution of sulfur and oxygen metabolism. The lines indicate fluctuations in concentration of atmospheric
oxygen (blue) and oceanic sulfide (orange) over evolutionary times. Atmospheric O2 was essentially absent from the
environment at the onset of life*3.8 bya. After the great oxidation event (GOE), the concentration of O2 in the atmosphere
increased, which was accompanied by a substantial increase in H2S. The first eukaryotes appeared in oceans and developed
in anoxic and sulfidic (euxinic) conditions for hundreds of millions of years using sulfur as their energy source, producing
RSS. During this time, defense mechanisms against RSS evolved, improving cell survival and minimizing the need for
repair of damaged cell constituents. Appearance of oxygenic cyanobacteria and plants led to increases in O2 levels and
oxidation of H2S and Fe
2+ *0.6 bya. Those changes were accompanied by a significant decrease in dissolved H2S and a
repurposing of enzymatic systems that originally evolved to protect organisms against RSS to serve additional antioxidative
protective functions. Mass extinctions (*, percentage of marine and land life) were often associated with a fall in ambient O2
and increases in H2S, perhaps providing a biological filter for descendants that retained some degree of tolerance to hypoxia
and sulfide. Modified with permission from Olson and Straub (139). bya, billion years ago; H2S, hydrogen sulfide.






















































H2S ( e )! HS ! H2S2 ( e )
! S2 ( e )! S2(n)
[3]
Thiyl radicals (HS), disulfane (H2S2), and persulfide
radicals (S2
-, supersulfide) thus generated can indeed be
very reactive and are either potent oxidants or reductants (see
The RSI: Sensing and Transducing Elements section), col-
lectively known as RSS.
Like ROS, RSS could have had dire consequences: or-
ganisms either had to acquire detoxification capability for
coping with RSS or die. These capabilities would have to be
different from those found in anaerobic organisms, which
could escape the oxygen by retreating to anoxic niches. For
organisms carrying out anoxygenic photosynthesis, retreat-
ing to asulfidic niches was not an option as these did not exist.
Therefore, safe disposing of RSS, or their use for signaling
or further metabolism, must have enabled the acquisition of
appropriate metabolic pathways long before oxygen became
prevalent. This would explain why antioxidant systems, such
as superoxide dismutase (SOD) (catalyzing reduction of
O2
-), catalase and glutathione peroxidase (catalyzing re-
duction of H2O2), and redox systems governed by thior-
edoxins, peroxiredoxins, and glutaredoxins, all appeared with
the advent of anoxygenic photosynthesis more than 2
bya before they would be called on to deal with ROS (21,
103, 124, 137, 221). Therefore, we suggest that—contrary to
common belief (8)—these systems evolved to detoxify RSS
and/or to shuttle reducing equivalents for energy utilization
or signaling. With the advent of O2, it would have been a
relatively trivial matter to switch from dealing with RSS to
ROS as their biological chemistries present more similarities
than differences. The use of multiple reactive species is in
alignment with the need to keep the composition of the in-
ternal environment (Claude Bernard’s milieu interieure)
relatively constant (83).
RSI for sensing and metabolic plasticity
The ready availability of energy in a usable form is a
fundamental requirement for survival and reproductive suc-
cess. In addition to defense and repair systems suitable to
cope with harsh environmental conditions, in a world of finite
resources, organisms require metabolic flexibility to respond
and adapt to changes in environmental conditions (Box 2).
The capability of early life forms to adjust their energetic
needs and metabolic capability to effectively respond to a
variable availability of nutrients/precursors requires an abil-
ity to sense and respond to those changes. This would in-
volve the capability to ‘‘sniff out’’ the prevailing conditions in
the extracellular environment and adjust metabolic pathways
accordingly. The metabolic plasticity required for this re-
sponsiveness in living organisms presumes the ability to se-
curely cope with reactive species. Reactive species are formed
mainly as enzymatic products from specific organic and in-
organic substrates, including amino acids, nitrite, polysulfides,
sulfite, sulfate, and O2 (as discussed in detail in the RSI Pre-
cursors in the Context of Intermediary Metabolism and Nu-
trition section). The RSI captures the interaction at the
interface between internal and external milieu that enabled
metabolic plasticity of early, unicellular life forms and persists
in regulating the intersection of co-metabolism and patho-
genesis in response to bacterial infection today (155).
From monocellular to multicellular life forms
The development of intercellular communication and the
emergence of symbiotic arrangements provided new collab-
orative opportunities to cope with environmental and infec-
tious threats as well as nutritional shortages. As discussed
for NO earlier (Box 4) (56), longer-lived RSI metabolites
may later have participated in cell–cell communication and
enabled co-metabolic negotiations. As levels of regulatory
complexity within those multicellular life forms increased, so
did the need for communication. Yet, without appropriate
protection, these symbiotic life forms were still vulnerable
to threats and dependent on opportunities provided by their
local environment. Gaining independence and resilience
against external stressors required formation of cell assem-
blies allowing robust growth and movement. This may have
been a driver for the development of larger multicellular
organisms with distributed critical functions and enhanced
resilience. With redox processes at the heart of global regu-
lation, all organisms larger than perhaps a few hundred cells
would require an internal system to communicate metabolic
activity status and perceived threat level throughout the entire
system, allowing bioenergetic prioritization to survive and
reproduce; in other words, an interorgan communication
system (see the Interorgan Redox Communication Systems
section for further details).
The RSI: Sensing and Transducing Elements
The rich chemistry of the RSI offers a unique opportunity
to fine-tune biological reactions, taking advantage of the di-
verse chemical nature and lifetimes of the intermediary
products formed. The interaction of RNS with ROS, exem-
plified by the formation of ONOO-, from O2
- and NO has
been conceptualized in the form of the chemical biology
of NO previously (65, 190). ROS/RSS interaction leads to
production of oxidized sulfur species, some of which can
further react with biological targets, including cysteine
thiolates, to generate, for example, persulfides. Much less is
known about the interaction of RSS with RNS to generate
S/N hybrid species. However, HSNO/SNO- and SSNO- are
prominent examples (37–39) that along with persulfides/
polysulfides (37–39, 41) garnered significant interest lately.
Persulfides and S/N-hybrid species have a chemical biology
with unique characteristics (37). The following section pro-
vides a brief overview of known interaction products of bi-
ological significance and discusses how their fundamental
chemistry dictates their kinetics of formation, action radius,
and biological reactivity and how they are particularly fit for
purpose in regulated biological systems (Box 3).
The chemical biology of the RSI: interaction
of NO, H2S, and O2 and derived species
It is becoming increasingly evident that the signaling and
physiological functions of NO, H2S, and O2 should be viewed
as components of an integrated whole (219) since they have
the potential to interact with each other and affect common
biological targets. A comprehensive treatment of all the
possible chemical/biochemical interactions between NO,
H2S, and O2 (and derived species) and their potential inter-
actions at common biological targets is an enormous under-
taking and beyond the scope of this review; other more






















































comprehensive treatments are available (5, 65). Therefore,
the possible interactive nature between NO, H2S, and O2 will
be discussed in very general terms. However, a more detailed
emphasis on sulfide species will be given because this is an
area of significant current activity with understanding of
much of the chemical biology of these functional groups
coming to light only recently.
Of all the small molecule bioregulators, the chemical bi-
ology of O2 is clearly the most studied and established. As the
ultimate electron acceptor for aerobic life, reduced O2 species
such as superoxide (O2
-), hydrogen peroxide (H2O2), and
hydroxyl radical (HO) are thought to be generated enzymat-
ically and nonenzymatically and possess biological relevance.
Indeed, all have been proposed to serve as cell signaling agents
and/or have pathophysiological consequences. All of these
species have been grouped together under the somewhat
misleading term ROS even though their reactivities are dis-
tinct, highly dependent on the cellular environment, and po-
tentially opposing. For the sake of brevity, it is probably best to
categorize the different entities according to their predominant
chemical attributes in tabular form (Table 2).
Akin to the term ROS, the equivalent terms RNS and
RSS denote NO-derived and H2S/RSH-derived species. Un-
doubtedly, these terms can be equally misleading since the
chemical reactivities of RNS and RSS are widely varying
and distinct. Regardless, the generation and predominant
chemical properties of the RNS and RSS are also listed in
Table 2. It is especially noteworthy that the interaction be-
tween ROS, RNS, and RSS can lead to products with distinct
(and even opposite) chemistry from that of the precursors. For
example, the reaction of NO with O2
- to make peroxynitrite
(ONOO-) takes two poor oxidants (NO and O2
-) and gen-
erates the potentially potent oxidant, ONOO-. As shown in
Table 2, ROS, RNS, and RSS taken together cover a wide
array of chemical properties ranging from highly reducing
(RSSH, O2
-) to highly oxidizing (HO, NO2), from highly
electrophilic (RSOH, H2O2, HNO) to highly nucleophilic
(RSSH), and from good hydrogen atom donors (HNO, RSSH)
to potent hydrogen atom abstractors (HO, NO2). This chemi-
cal diversity allowsNature to take advantage ofwidely varying
interactive chemistries provided by a limited number of bio-
chemical precursors (namely O2, NO, H2S, and derived spe-
cies). The cellular conditions conducive to formation of these
species imply a selective pressure toward systems that enable a
high level of control together with the regulation of cellular
function with appropriate biochemical transformations. For
Box 4. Evolution of the RSI – From Sulfur and Nitrogen to Oxygen
Life is believed to have evolved in a sulfur-rich atmosphere essentially devoid of oxygen, developing bottom-up, first by
simple chemical interaction (protometabolism) between atmospheric constituents and reactive materials present on/
transported to the Earth’s surface comprising redox-active metals, H2S, CO, H2, CH4 and NH3 (not discussed in the present
article due to space constraints), nitrogen oxides (NO, NO2. N2O3, NO2
2, NO3
2) and sources of carbon. Lipid-like
membranes would have allowed compartmentalization and formation of primitive single-celled self-replicating organisms
feeding on finite local substrates to fulfill their energetic demands. According to this view, the chemical biology of RSS,
and their interaction with RNS and later on with ROS governed the emergence and evolution of Life. Furthermore, to cope
with reactive species cells had to develop detoxifying systems early on. Interestingly, the detoxifying systems are also
based on sulfur-containing elements (i.e. thiols), and NOmay have played a key role in intercepting other free radicals. The
dynamic and rapid equilibria among RSS and detoxifying systems have probably been one of the most powerful driving
forces connecting cellular metabolic capacity with the extracellular milieu, allowing cells to find multiple ways to survive
and increase their robustness; this may have included adaptation to changes in the environment and communication to other
cells, driving the emergence of symbiotic niches and the development of multicellular organisms.
NO was the first among the reactive species to be proposed to have played a key role in intercellular communication and
development of Life on Earth (56) well before the need to deal with the adverse consequences of rising atmospheric O2
levels in the form of unintentional cellular ROS generation (56). We do not know with any certainty where, when and how
Life on Earth began – similarly little is known about the onset of biogenic NO formation. Geochemically, NO/NOx would
have been formed as a result of lightning and volcanic activity. Since contemporary eukaryotic NO synthases require O2 to
generate NO from L-arginine this process would not have worked reliably under hypoxic conditions; biological NO
production must therefore have originated from simpler prokaryotic processes such as denitrification (the process of nitrate
reduction to dinitrogen) and/or ammonia oxidation (56) where both NO2
- and NO are reaction intermediates.
There is an astonishing redundancy and abundance of nitrite reductases in contemporary cells of all kingdoms. One
characteristic of eukaryotic nitrite reductases is their susceptibility to inhibition by O2 (55). It is possible that multiple NO
producing systems coexisted side-by-side, depending on whether the environment was reducing or oxidizing in nature,
what substrates were available and what other biochemical processes this could be linked to. Several atypical NO synthases
have meanwhile been discovered in fungi and bacteria (44), and it is likely that other non-classical NO producing enzymes
will be identified in other life forms in the future. The nitrogen cycle is probably of similar antiquity as the sulfur cycle since
both N and S are essential for Life. Nitrogenase is arguably the most important enzyme in the process of nitrogen fixation
by allowing the reduction of N2 to NH3, a key step that enables the incorporation of nitrogen into amino acids, nucleotides
and other essential biomolecules. Nitrogenase is produced by cyanobacteria (blue-green algae), green sulfur bacteria and
several symbiotic bacteria such as those living on the roots of leguminous plants. The enzyme is oxygen-sensitive and
comprises an iron-containing protein that supplies electrons to the FeMo protein, which uses those electrons to reduce N2 to
NH3, forming H2 as a by-product. The FeMO protein contains a 4Fe-4S and aMo-3Fe-3S cluster held in place by a cysteine
and a histidine on either end. The presence of iron, molybdenum and sulfur suggests a hydrothermal heritage (135). Thus,
there is precedence for early interaction between sulfur and nitrogen metabolism long before the emergence of oxygen.






















































Table 2. Chemical Attributes of Reactive Oxygen Species, Reactive Nitrogen Species,
and Reactive Sulfur Species (Interactions with Metals and Metalloproteins Not
Included in This Overview)
Species Occurrence/formation Chemistry
Dioxygen, O2 Aerobic life Has unpaired electrons—reacts readily with
other radicals, poor 1e- oxidant, but other-
wise easily reduced by 2, 3, and 4e-.
Superoxide, O2
- 1e- reduction of O2 Has one unpaired electron. Good reductant.
Under acidic conditions, it can be an oxidant.
Reacts with other radicals.
Hydrogen peroxide, H2O2 1e
- reduction of O2
- Two-electron oxidant. Electrophilic. Not a rad-
ical species. Can modify RSH (below).
Hydroxyl radical, HO 1e- reduction of H2O2 Potent 1e
- oxidant. A short-lived radical species
capable of abstracting an e- or hydrogen atom
from most biological molecules.
Nitric oxide, NO Enzymatic, NO2
- reduction Has unpaired e-. Poor oxidant. Reacts with
other radicals (O2 and O2
- and other organic
radicals [R]). Can quench radical chemistry.
Nitrogen dioxide, NO2 Oxidation of NO Good 1e
- oxidant. Radical species. Reacts with
other radicals (can make R-NO2 when reacted
with R).
Dinitrogen trioxide, N2O3 Oxidation of NO by O2 Not a radical. Electrophilic and can nitrosate
nucleophiles (add equivalent of NO+).
Synthesis only relevant at high concentrations
of NO.
Peroxynitrite, ONOO- Reaction of NO and O2
- Not a radical, but can generate both HO and
NO2. Rearranges to give nitrate (NO3
-). Can
oxidize by 2e- (via peroxide-like chemistry).
Nitroxyl, HNO S-nitrosothiol reduction Reacts readily with thiols. A good hydrogen
atom donor. Can act as an antioxidant by
quenching radical reactions.
Nitrite, NO2
- Oxidation of NO, dietary Unreactive at neutral pH. Not a radical.
Nitrosating agent under acidic conditions.
Can be reduced to NO (under acidic condi-
tions).
Hydrogen sulfide, H2S Geochemical, enzymatic Good metal ligand. Not a radical. Can react with
other biological electrophilic sulfur species
(e.g., RSSR, RSOH).
Thiol, RSH Endogenous (e.g., cysteine) Good metal ligand. Not a radical. Can be
oxidized to give other biologically relevant
sulfur species.
Thiyl radical, RS$ 1e- oxidation of RSH Radical species. Good 1e- oxidant. Will react
with other radical species such as NO.
Disulfide, RSSR Oxidation of RSH Not a radical. Electrophilic. Can be reduced
back to RSH under biological conditions.
S-Nitrosothiols, RSNO Nitrosation of RSH Not a radical. Can be reduced to RSH and HNO.
Can transfer NO+ to another thiol
(transnitrosation).
Sulfenic acid, RSOH 2e- oxidation of RSH Not a radical. Electrophilic (reacts with other
thiols to give disulfides, RSSR).
Hydropersulfide, RSSH Enzymatic Not a radical. Superior nucleophile and can be
electrophilic (akin to RSSR). Good 1e-
reductant. Readily reduced back to RSH.
Hydropolysulfide, RSSnH Oxidation of RSH Properties similar to RSSH (although enhanced
in all aspects).
Dialkyl polysulfide, RSSnR Oxidation of RSH Properties similar to RSSR (although enhanced
in all aspects). Can also be nucleophilic.
SSNO- Unknown, to be determined Fairly stable. Appears to be a source of NO.
Chemical properties pending.
SNO- Unknown Fleeting. Chemical properties pending.






















































sensing/signaling purposes, the biochemical syntheses ofROS,
RNS, and RSS must be tightly controlled kinetically, tempo-
rally, and spatially.For example,NObiosynthesis canoccur via
three primary pathways involving NOS enzymes that are dis-
tinct with regard to their regulation and location (40, 58). The
generation of NO2 from NO is kinetically second order in NO
and first order in O2, indicating that significant NO2 levels (at
least made via NO/O2 chemistry) can only be produced in
compartments possessinghigh levels of bothprecursors such as
lipidmembranes (115).Of note, nitrogen oxide-modified lipids
(containing nitrated fatty acids) possess potent biological ac-
tivities (156). Moreover, significant generation of ONOO- re-
quires that both NO and O2
- be made at the same place, rate,
and time (96). This requirement makes ONOO- generation
rather difficult, possibly protecting cells from inadvertent for-
mation and narrowing its action radius.
S-nitrosothiol formation can occur in several ways (37,
65). One possibility is the reaction of a free thiol with a
nitrosating species, that is, an entity that donates the equiv-
alent of NO+ such as N2O3. Another possibility is the reaction
of a thiyl radical with NO. Importantly, N2O3 generation is
kinetically restricted (214) (for similar reasons as NO2 gen-
eration); as a one-electron oxidant, thiyl radical is very re-
active and its formation can only take place under very
specific conditions, such as at the active site of enzymes such
as ribonucleotide reductase (184). These strict chemical re-
quirements offer a selective advantage by limiting the gen-
eration of unwanted reactive and/or deleterious species,
which ensures that they are only formed under specific con-
ditions for a particular purpose. By contrast, inadvertent or
aberrant generation of any ROS, RNS, or RSS carries the risk
of pathophysiological consequences.
Finally, RSS receiving considerable recent attention are
hydropersulfides (RSSH). Generation of hydropersulfides
from the corresponding thiol represents an oxidation (an
RSSH species is at the same oxidation state as a disulfide,
RSSR) and can be mediated by several of the oxidants listed
in Table 2 (e.g., H2O2 in the presence of H2S). Interestingly, a
hydropersulfide is a superior reductant compared with the
corresponding thiol. Thus, an extremely potent reductant
(RSSH) is made primarily under oxidizing conditions, a fact
that seems to have been taken advantage of in nature as it has
been proposed that RSSH formation can be protective against
oxidative stress (140).
Since RSS are relatively new players in the RSI, some
more space is allotted here to the discussion of these species.
The chemistry of persulfides/polysulfides
One of the most well-established reactions of H2S in bio-
chemistry is that with disulfides (10, 60, 140). Reaction of
H2S with RSSR yields an equilibrated system involving the
corresponding persulfide (RSSH) and thiol (RSH) species
(Eq. 4).
RSSRþH2SÐ RSSHþRSH (4)
RSSH species display a unique chemistry that differs from
that of RSH and H2S, conferring potential advantages in bi-
ology.
In comparison with RSH, RSSH is both more nucleophilic
and reducing. The greater nucleophilicity of RSSH can be
explained by (i) the a-affect, in which the electrons of the
internal sulfur atom repel those of the external sulfur atom,
thus enhancing nucleophilic reactivity—a characteristic
lacking in RSH, and (ii) the pKa of RSSH typically being 1–2
units lower than analogous RSH species, making the anionic
RSS- present in greater concentrations than RS- at physio-
logical pH.
RSSH is also a more potent one- and two-electron reduc-
tant than RSH. The greater two-electron reducing ability of
RSSH can be explained by its greater nucleophilic character.
The fact that RSSH is a better one-electron reductant than
RSH is explained by the stability of the corresponding per-
thiyl radical (RSS) over that of the thiyl radical (RS).
Formation of RSS leads to a resonance-stabilized unpaired










Last and perhaps most intriguing, RSSH are also electro-
philic species, whereas RSH are not. Consideration of the
oxidation state of sulfur atoms in RSSH reveals that both are
in a -1 oxidation state. By comparison, the oxidation state of
the sulfur atom of RSH is -2 and therefore RSSH is oxidized
with respect to RSH. In this light, RSSH are similar to RSSR
(in which both sulfur atoms are also in the -1 oxidation state)
and thus are also able to act as an electrophile. Indeed, the
electrophilic ability of RSSH is expected to be a function of
pH as the deprotonated RSS- species is considered to be less
electrophilic (and more nucleophilic) than the protonated
RSSH. Electrophilic reactivity of RSSH can yield H2S (via
nucleophilic attack on the internal sulfur) or result in a
transsulfuration process (via nucleophilic attack at the ter-
minal sulfane sulfur), yielding another RSSH species (Eq. 6)
or inorganic polysulfides (i.e., HSSH; Eq. 7).
RSSHþR¢SHÐ RSHþR¢SSH [6]
RSSHþH2S Ð RSHþH2S2 [7]
S/N hybrid species
Although several groups have investigated the interaction
of RSH and nitrogen oxides, specifically NO, mechanisms for
the formation of resulting species in biological systems are
still controversial. Therefore, the possible reactions of RSH
and other related species with NOwill be discussed here from
a chemical standpoint and implications for biological rele-
vance will be given based on this. As alluded to above, S-
nitrosothiols have been reported to have important biological
function and serve as biological signaling molecules (17, 59,
179). However, no direct reaction between RSH and NO
should be expected to produce such RSNO species because
NO has an unpaired electron that occupies an NO antibonding
orbital, preventing nucleophilic attack by RSH. However,
oxidation of RSH to the corresponding RS allows for reac-
tion with NO, yielding RSNO (Eq. 8).
RSH
![O] RS !NO RSNO [8]
Other pathways leading to RSNO formation include RSH
reaction with products from the reaction of O2 and NO (i.e.,






















































N2O3, Eq. 9) or by reaction with metal nitrosyl complexes in
which the NO ligand acts as a nitrosonium ion (i.e., Fe2+
-NO+, Eq. 10). For example, coordination of NO to a ferric
iron species (Fe3+) can generate a ferric nitrosyl complex
[Fe3+-NO; also described as {Fe(NO)]6 using the Enemark–
Feltham notation for metal nitrosyls). This species can be
viewed as having significant ferrous nitrosonium character
(Fe2+-NO+) and thus can serve as a source of NO+ when
reacting with appropriate nucleophiles.
RSHþN2O3!RSNOþNO2 þHþ [9]
RSHþ Fe2þNOþ
!RSNOþ Fe2þ þHþ [10]
Likewise, similar reactivity is predicted for HS- (in com-
parison with RSH), theoretically leading to formation of
HSNO. For the same reasons as outlined for RSH above, no
direct reaction between HS- and NO should occur to any
significant extent.
Like RSH, RSSH is not expected to react directly with NO.
Although one-electron oxidation of RSSH and coworkers to
RSS might be expected to yield the corresponding alkyl-S-
nitrosopersulfide (RSSNO) via reaction with NO, recent
studies indicate this either does not occur to any great extent
(10) or the product has a short lifetime (2). For this reason,
RSSNOmay not be expected to serve as a biological signaling
molecule or NO transporter. Curiously (and unlike thiyl radi-
cals), RSS is rather stable even in the presence of O2 (10),
offering potential opportunities for electron transfer reactions
under aerobic conditions (see the Intracellular Redox Reg-
ulation, Bioenergetics, and IntermediaryMetabolism section).
Contrary to the presumed instability/reversibility ofRSSNO,
SSNO-ii (37) appears to be relatively stable [a result of the
resonance-stabilized anion (10, 120)], existing for extended
periods of time even in the presence of other RSH species (39,
41). Although SSNO- has been observed to form under various
conditions, including reaction ofNOwith H2S and polysulfides
(HSSnH, n‡ 2) (41, 120), the exact mechanism for SSNO-
formation is unknown. However, it is reasonable to consider
that SSNO- is made via reaction of NO with trace polysulfide
contaminants present inH2S sources. For example, the presence
of trace S2
- (a possible result of one-electron oxidation of S2
2-
or homolytic cleavage of S4
2-), which is a species well recog-
nized by sulfur chemists to exist in salt melts and heated non-
aqueous solutions of sulfur (181), could be expected to react
directly with NO, yielding SSNO- (37) (Eq. 10).
S2
 þNOÐ SSNO [10]
It should be noted, however, that to date, SSNO- has yet to
be observed in a biological system, leaving its relevance and
biological formation still uncertain. Nevertheless, pharma-
cological SSNO- has been shown to release NO, dilate blood
vessels, and activate the prototypical Nrf2 stress response
pathway (39, 41, 42).
Cysteine-based redox switches and redox relays
Free sulfhydryl (-SH) groups in low-molecular-weight
thiols such as cysteine, peptides (such as GSH), and proteins
(e.g., albumin) are predominant targets of RSI signal trans-
duction; others include methionine, tryptophan, tyrosine, and
histidine moieties, but their functional significance is not
fully understood.
Cysteines may serve structural, catalytic, and regulatory
functions in proteins and are considered redox switches as
they are targeted for oxidation, nitrosation, thiolation, and
sulfidation (also termed sulfhydration). Therefore, rather than
on/off switches, protein cysteines may act as multistage cyste-
ine relays (Fig. 3), allowing cells to dynamically adjust protein
structure and enzymatic function according to the local redox
state (100, 216). In addition to protein thiols, low-molecular-
weight thiols, including cysteine and glutathione, are important
contributors to intracellular and, via mixed disulfide formation,
possibly also extracellular redox status (see section ‘‘Interorgan
RedoxCommunicationSystems’’ andcorrespondingFig. 5).To
function as regulatory elements, those thiol-based post-
translational modifications must be also under kinetic control.
This is achieved by coupling cysteine-based modifications to a
battery of target-specific reductases, denitrosylases, and de-
sulfurases, which together are able to maintain low steady-state
concentrations of thiolmodifications; these include thioredoxin/
thioredoxin reductase, glutaredoxin, peroxiredoxins, and other
enzymes (68). Both thiol modifications and their regeneration
are dynamically linked to global redox and nutritional status
(see the RSI Precursors in the Context of Intermediary Meta-
bolism and Nutrition section and Fig. 1).
Biological targets of the RSI
The net biological effects of the reactive species are deter-
mined by the nature, level of expression, and function of the
biological targets carrying functional cysteine redox switches
(Box 1 and Fig. 1). Examples include protein kinases and
phosphatases, ion channels, transporters, and enzymes (e.g.,
those involved in intermediary metabolism), allowing rapid
short-term adjustments (Fig. 1). In addition, longer-term reg-
ulation is achieved by interaction with redox-sensitive tran-
scription factors, for example, Nrf2/Keap1, NFkB, and HIF
(54). Even longer-persisting effects are achieved by redox
regulation of gene expression under epigenetic control,making
redox effects transmissible to the progeny. This notion is con-
sistent with the developmental origin of health and disease
(DOHaD)paradigm,which provides amechanistic explanation
for the pathophysiological basis of how environmental influ-
ences experienced during early embryonic development may
influence the risk of noncommunicable diseases later in life and
across generations (71, 77, 217) (see also the section ‘‘Per-
spective: How Redox Biology and Insights into the Regulation
of the RSI May Transform Personalized Medicine’’).
Functional significance of the RSI
A corollary of the RSI concept is that reactive species can
no longer be regarded as mere stressors (Box 1). Rather, they
should be considered controlled reaction products, which
serve to sense and transduce information about any changes
of internal and/or external conditions; as such, they may
be considered as elements of a regulatory system (the RSI)
iiWe here use the most traditional notation of perthionitrite
(SSNO-) as the molecule was originally named by Fritz Seel and
coworkers [see Cortese-Krott et al. (37) for a comprehensive re-
view]; however, the notation as nitrosopersulfide (ONSS-) is also
correct.






















































that enable an integrated response to various forms of stress,
for example, changes in metabolic, nutritional, and redox
status, and environmental conditions (Box 5). See also Boxes
1, 2, and 5.
RSI Precursors in the Context of Intermediary
Metabolism and Nutrition
The RSI is driven by specific substrates for enzymatic
production of individual ROS, RNS, and RSS. Local pro-
duction of reactive species depends on the availability of O2,
certain amino acids, and cofactors, as well as the activity of
specific enzymes, which together are embedded within an
intricate system of intermediary metabolism that determines
the pattern and rate of fluxes according to synthetic and en-
ergetic needs (Fig. 4). Given the fundamental role redox
regulation plays in cellular defense, repair, and survival, the
balance of metabolic fluxes must be prioritized to first sup-
port an adequate redox status before fulfilling local metabolic
needs. The following section provides a short overview of the
precursors needed for ROS, RNS, and RSS synthesis in the
context of dietary intake and human nutrition (Fig. 4).
Precursors of ROS, RNS, and RSS:
the oxygen–arginine–methionine metabolome
Unsurprisingly, in aerobic organisms, oxygen sensing
is intimately linked to intermediary metabolism (1). ROS
Box 5. Chemical Biology and Functional Significance of the Reactive Species Interactome
ROS were initially viewed as mere by-products of redox reactions, especially mitochondrial respiration and certain
pathological conditions, leading to oxidative damage of biological targets (protein, lipids, DNA). Furthermore, oxidative
reactions were believed to be mediated by RNS, mainly produced by the oxidation of NO. Similarly, cysteine oxidative
modification and formation of RSS were first considered only as a consequence of pathological conditions (67). Today,
reactive species are considered part of a complex redox signaling network that interacts with protein thiol targets, which act
as redox switches to control protein structure and function in dependence of local and global redox and environmental/
nutritional status. The analysis of the chemical biology of H2S and related sulfane sulfur species and their interaction with
NO and ROS indicate that the RSI is a tightly intertwined redox network that enables rapid sensing and adaptation of the
internal cellular milieu to a changing environment. As indicated in Box 1, it is noteworthy that this redox metabolic
network appears to have evolved in a world dominated by sulfur and only later incorporating the wider range of options
involving nitrogen and oxygen species. This is exactly the opposite order as to how these species were discovered and
discussed as contributors to redox biology in the literature. The basis of the interactions among the reactive species in the
RSI is defined by the fundamental chemistries of their atomic constituents. However, to be able to operate effectively and
enable regulatory control, the system also requires an ability to sense, respond, and adapt to the prevailing state. This is
achieved by subjecting both formation and elimination of reactive species and their downstream metabolites to kinetic
control through the activity of specific enzymes.
FIG. 3. Cysteine modifications induced by interaction with ROS, RNS, and RSS. The reactive species interactome
consists of the interaction of reactive species (ROS, RNS, and RSS) with one another andwith cysteine thiols as redox switches
(reactions with other functional groups omitted here for the sake of simplicity). The outcome of these interactions depends on
the chemical characteristics of the species inducing the modification (e.g., O2
-, H2O2, NO, ONOO
-) and their fluxes and the
environmental conditions (e.g., pO2, pH), as well as on the reactivity and localization of the targeted cysteines. The lines
indicate the outcome of protein cysteine modifications induced by RNS (blue), ROS (red), or RSS (orange).






















































production involves a variety of different enzymes and or-
ganelles utilizing oxygen, but the relationship is not straight-
forward; counterintuitively, more mitochondrial O2
- is
produced in hypoxia than under normoxia (207). O2 is also the
substrate of various NADPH oxidases producing either O2
- or
H2O2 (16, 199). Other sources include xanthine oxidoreduc-
tase, 5-lipoxygenase, and cytochrome P450. Nonenzymatic
ROS production may also be generated in an unregulated
manner through the metal-driven Haber–Weiss reaction lead-
ing to the formation of OH. Enzymatic generation of NO
requires both a source of N and O, specifically in the form of
arginine (and possibly homoarginine) and O2 (72, 127, 167),
whereas NOS-independent reactions leading to NO formation
include nitrite/nitrate reduction (43, 90, 116, 172, 192). NOS
activity is also dependent on tetrahydrobiopterin and reducing
equivalents in the form of NADPH (72, 185). RSS production
relies on the availability of methionine, homocysteine, and
cysteine serving as substrates in the methionine recycling and
transsulfuration pathway. The enzymes of the transsulfuration
pathway are responsible for the formation of cysteine from the
essential amino acid methionine and serine. Cysteine is crucial
for defining protein structure (disulfide bonds), function (e.g.,
enzymatic activity), redox signaling (e.g., by acting as redox
switches, see The RSI: Sensing and Transducing Elements
section), and as a building block for glutathione (GSH) pro-
duction. The tripeptide GSH (Glu-Cys-Gly) is less toxic for
cells than cysteine itself, is present inmillimolar concentrations
intracellularly, and buffers the cellular antioxidant network,
together with ascorbate (vitamin C), ubiquinol (coenzyme Q),
and a-tocopherol (vitamin E) (175). The two other amino acids
critical to GSH synthesis are glycine (itself, in part, derived
from serine) and glutamine (formed from glutamate and in-
teraction with proline) (see Supplementary Fig. S1; Supple-
mentaryData are available online atwww.liebertpub.com/ars).
Cofactors such as folate, choline, vitamin B6 (pyridoxal
phosphate), and B12 (cobalamin) are critically important for
adequate methionine recycling. Interestingly, several meta-
bolic aberrations in the tetrahydrofolate cycle, the methionine
recycling capacity, or flux through the transsulfuration path-
way are associated with elevated homocysteine concentrations
in blood. The latter marks metabolic imbalance and/or inade-
quate nutrient availability and hence is a marker of risk for
cardiovascular disease (95, 138). The transsulfuration pathway
enzymes, cysteine-b-synthase (CBS), cysteine-c-lyase (CSE),
and 3-mercaptosulfotransferase (MST), are also responsible
for the endogenous production of H2S (144) as well as organic
persulfides (CBS) (86) and polysulfides (3-MST) (101, 102).
CBS is functionally regulated by NO, its expression enhanced
by oxidative stress, and gene transcription hormonally regu-
lated in response to fuel supply (182). These pathways there-
fore can be considered to be a central hub for intermediary
metabolism and a point of intersection for the production of
proteins (as building block for tRNA and ribosomal protein
synthesis), lipids (via S-adenosylmethionine and choline), and
FIG. 4. Metabolic pathways fueling the RSI. In mammals, L-arginine is formed from citrulline, derived either from
dietary glutamine or proline via ornithine and carbamoylphosphate in the mitochondria or from bicarbonate (HCO3
-) and
ammonia (NH3) via the hepatic urea cycle. Citrulline is then transported via the blood to the kidney where it is converted into
arginine. Arginine used for protein formation and (O2-dependent) NO synthesis can be recycled via the arginine/citrulline
cycle. NOS activity is inhibited by different methylated arginine residues released by proteolysis (e.g., ADMA). A key
interaction between nitrogen and sulfur metabolism is the methylation of arginine using SAM-dependent methyltransferases.
SAM is a cofactor produced from methionine and used for methylation of a large number of biomolecules; in the methionine
recycling pathway, the removal of one methyl group (-CH3) results in the formation of homocysteine. Depending on the
availability of methionine, homocysteine is either recycled to methionine with the help of vitamin B12 and folic acid or is
degraded to cystathionine and cysteine. While the latter also serves as precursor of cellular glutathione production, both
compounds can generate H2S in the transsulfuration pathway. Not shown here is the formation of ROS via NADPH oxidases,
the mitochondrial respiratory chain, and other sources. See Supplementary Figure S1 for more details. ADMA, asymmetric
dimethylarginine; NOS, nitric oxide synthases; SAH, S-adenosyl-homocysteine; SAM, S-adenosyl-methionine.






















































methylation reactions (via S-adenosylmethionine), as well as
GSH production and H2S/persulfide signaling. This is in ac-
cordance with the recent discovery that the nearly 4 billion-
year-old metabolism of the last universal common ancestor
(LUCA), the forerunner of all contemporary life forms on
Earth, already relied on S-adenosylmethionine-dependent
1-carbon metabolism to make a living by harnessing energy
from its primordial geological environment (208).
The interaction of H2S, NO, and O2 is tightly linked to
bioenergetics through their convergence in the regulation of
mitochondrial function. In cultured cells, hypoxic stress in-
duces CSE translocation from the cytosol to mitochondria to
sustain ATP production, presumably via fine-tuning of the
electron transport chain and use of sulfide as a mitochondrial
substrate (63, 78, 188). Marked changes in metabolic needs
and/or mitochondrial function are likely to affect precursor/
cofactor availabilities and therefore RSI-mediated sensing
and adaptation processes (Box 6).
How nutrition affects precursor availability
L-arginine uptake and metabolism in the human body. In
addition to its role in protein biosynthesis, arginine is a pre-
cursor for creatine and NO production. There is the need for
endogenous formation of arginine, and for young growing
mammals, it has to be provided in the diet (i.e., it is an es-
sential amino acid), but less so in adulthood, where it can be
considered to be conditionally essential. (189). Inadequate
availability of arginine has been associated with T cell and
endothelial dysfunction (129); these effects are not usually
observed in healthy adults (24) as endogenous synthesis is
sufficient to meet usual demands, except in situations of cat-
abolic stress (e.g., inflammation or infection) (128). The net
rate of endogenous de novo arginine synthesis is modulated in
relation to provision from the diet and the breakdown of
proteins (28).
There is evidence for de novo synthesis of arginine in
enterocytes up to the age of 3–5 years (202, 212). Beyond
this, more complex interorgan amino acid cooperativity is
required, which involves enterocytes and the renal cortex (14,
48, 213) (known as the intestinal–renal axis). In enterocytes,
endogenous and dietary glutamine is converted into citrulline
via glutamate and ornithine (218). Circulating citrulline is
then taken up by cells in the renal cortex and converted into
arginine (14, 48, 213). The conversion of argininosuccinate
to arginine, the final step in arginine de novo synthesis, re-
quires argininosuccinate lyase, which is almost exclusively
found in the renal cortex. Hepatic arginine synthesis is em-
bedded in the metabolic pathway of the urea cycle and
therefore results in high flux, but low net production (218).
Approximately 60% of net arginine synthesis occurs in the
kidney. However, renal insufficiency does not result in de-
creased plasma arginine concentration, but in increased cit-
rulline levels (112, 218). The mechanisms underlying the
maintenance of plasma arginine concentration are poorly
understood, but may involve a compensatory decrease in
arginine utilization (28).
Only a small proportion (*1%) of the overall arginine
turnover, but a considerable amount (54%) of circulating ar-
ginine, is used for NO production (27). In healthy human
adults, the production of NO from L-arginine corresponds
to*1mmol/day (173). Citrulline, one of the products of NOS,
can be recycled by transamination to arginine via the so-called
citrulline/NO cycle or arginine/citrulline cycle (76, 218), al-
though in vitro this cycle is much less efficient than the he-
patic urea cycle (218). Of note, the guanidino nitrogen group
used to form NO is mostly not derived from dietary arginine,
but from carbamoylphosphate and aspartate (see Supplemen-
tary Fig. S1).
Arginine moieties in proteins can be methylated to form
mono- and dimethylated derivatives, which are released into
the circulation upon proteolysis. Circulating concentrations
of two of these methylated arginine derivatives (L-NG-
methylarginine and asymmetric dimethylarginine) are effective
inhibitors of cellular arginine uptake and NOS activity (113).
While symmetric dimethylarginine does not act as a direct
NOS inhibitor, it can reduce NO production by competing
with arginine transport (13).
Methionine recycling, transsulfuration, and one-carbon
metabolism. Methionine and cysteine are the two sulfur-
containing amino acids (SAAs) incorporated into proteins.
Methionine is one of the most hydrophobic amino acids. It
has important physiological roles, including the initiation of
translation via initiation tRNA (met-tRNAi
met) and methyl-
ation pathways via S-adenosylmethionine (18, 182), which
are important for the formation of cofactors such as biotin and
lipoic acid. Despite its importance in physiology and being
the seventh most abundant element in higher vertebrates, the
extent to which the dietary provision of sulfur-related com-
ponents adequately supports the needs of sulfur metabolism
has received inadequate attention (87, 134).
The main sources of sulfur in the diet are inorganic sulfate
(SO4
2-) and SAAs.Methionine can be converted into cysteine,
andwith a sufficient supply of the former, adequate amounts of
the latter can be formed endogenously from serine. However,
Box 6. Reactive Species Interactome Precursors and Cofactors
The precursors and cofactors required to support the functioning of the RSI belong to the oxygen–arginine–methionine
metabolome and originate from the same pathways that provide the basic building blocks for proteins, lipids, methyl groups, and
DNA/RNA synthesis and are thus important for cell proliferation and repair; this suggests competition between anabolic events
and redox signaling. The RSI also regulates the expression and activity of enzymes belonging to intermediary metabolism and
stress response, highlighting the interactions between catabolism, bioenergetics, and redox status. The reciprocal nature of these
relationships indicates that theRSI serves as a central hub that integrates intermediarymetabolism and stress signaling (Fig. 1). In
addition, tissue/organ functions need to be coordinated and integrated for the sake of optimal fitness of the entire organism; this is
achieved via a central communication system, that is, blood, transporting gases, nutrients, and waste products, as well as
erythrocytes, immune cells and platelets. Considering the fundamental role of blood in maintaining systemic homeostasis, the
RSI itself may participate in systemic redox regulation (see also the Interorgan Redox Communication Systems section).






















































as this reaction is irreversible, methionine has to be provided
preformed in the diet regardless of cysteine status (152).
Dietarymethionine is absorbed rapidly andalmost completely,
and only small amounts are excreted directly following bolus
administration. It is eliminated from plasma with a half-life of
*150min and a threefold increase in urinary SO4
2-, another
important product of transsulfuration (85).
Healthy adults are in sulfur balance with equilibrium be-
tween intake, transsulfuration, and excretion. The conversion
of methionine to cysteine via homocysteine is the only cat-
abolic pathway of methionine. Sulfur is excreted via the
kidney mainly as free sulfate (SO4
2-, 77%–92%), esterified
sulfate (7%–9%), taurine (2%–6%), cyst(e)ine (0.6%–0.7%),
and minor amounts of methionine, homocysteine, cy-
stathionine, N-acetylcysteine, mercaptolactate, mercaptoa-
cetate, thiosulfate, and thiocyanate (182). The net changes
represented by external balance do not adequately capture the
considerable internal flux associated with the turnover of
methionine and cysteine into and from protein and peptide
pools, estimated as 32 and 38mmoles per day, respectively
(19). Although the daily production of H2S has not been
quantified, it is likely considerably higher than that of NO.
Homocysteine represents a determinant branch point for
methionine flow either to cysteine through transsulfuration
via pyridoxal phosphate-dependent CBS and CSE to cy-
stathionine and cysteine or remethylation via betaine, folate,
or vitamin B12 (cobalamin)-dependent pathways (89, 177)
(Fig. 4 and Supplementary Fig. S1). Under physiological
conditions, there is a similar flow through each pathway
(183), but changes in methionine supply or the relative
availability of donors for methylation modify the flow
through these pathways. Low methionine availability results
in high transsulfuration rates (presumably secondary to sys-
temically increased ROS production), whereas a replacement
of methionine by cysteine results in increased remethylation
(49). Importantly, modulation of dietary SAA intake can
affect plasma redox status (93).
Methionine homoeostasis is achieved by modulation of the
balance of protein turnover and the relative rates of trans-
sulfuration and remethylation (64, 151, 152, 183). The re-
ductive adaptations developed during malnutrition limit the
capacity for handling large doses of methionine, leading to a
high plasma concentration of methionine (178) and increased
concentration of homocysteine (88). Similar to poor vitamin
B6 status and limited serine availability, perturbations in
amino acid status can result in homocysteine accumulation,
increased remethylation to methionine, and a concomitant
reduction in flux through the transsulfuration pathway.
Overall, methionine maintains a very stable plasma concen-
tration at the expense of endogenous sulfate production (87).
The sulfur/nitrogen relationship. In adults consuming a
normal diet, there is a strong correlation between urinary
sulfate and dietary SAA intake, and urinary S:N ratio reflects
dietary S:N ratio (157, 171). This relationship is, however,
modulated by unusual dietary patterns, for example, during
starvation or on low-protein diets when postprandial urinary
sulfate excretion is reduced to a greater extent than urea
excretion (74, 97, 118, 119). This suggests that protein re-
striction results not only in preservation of SAA and re-
plenishment of the nonprotein SAA pool but also complex
and tight interconnections between the metabolic pathways
of nitrogen and sulfur metabolism to maintain constant
plasma concentrations of methionine. Thus, alterations in the
S:N ratio of urinary metabolites may hold promise as indi-
cators of a stressed system with unusual metabolic demands.
Impact of microbial–host co-metabolism
on components of the RSI
Besides the above mammalian pathways, H2S may also be
generated from isothiocyanates, which are particularly
prevalent in Brassica vegetables such as broccoli (23, 32),
polysulfides contained in garlic (7), and via gut microbial
reduction of dietary sulfate (SO4
2-) (23), cysteine, and pro-
tein (23, 119). Microbial H2S generation may contribute to
the total body pool of sulfide (170) and may even have blood
pressure-lowering effects (191). Likewise, dietary nitrite and
nitrate can be reduced by the oral and gut microbial flora to
NO, contributing to circulating nitrite levels and mildly lower
blood pressure (25, 117); together with the enterosalivary
recirculation pathway, this has become known as the mam-
malian N-oxide cycle (25, 116). It is conceivable that a
similar sulfur cycle exists in mammalian organisms and those
pools of H2S and NO may give rise to reactive species, in-
cluding ONOO- and possibly SSNO- (37, 39, 41). Fluctua-
tions in intestinal oxygen gradients may further shape the
redox relationships between the gut microbiome and the host
metabolome (53).
Interorgan Redox Communication Systems
One of the primary functions of the circulatory system in
mammals is to efficiently transport oxygen, nutrients, and
waste products around the system. With one exception (136),
little consideration has been given to its further potential role
in acting to communicate and maintain whole-body redox
status in relation to external environmental conditions and
internal metabolic needs.
Individual cells within a given tissue/organ need to sense
their microenvironment in relation to that of the entire or-
ganism to achieve a metabolic status that adequately enables
the needs of their preferred activity (Box 5). Similarly, the
cells need to relate their individual redox status within a
composite redox state that matches with other cells and or-
gans. This necessitates reciprocal sensing of intra- and ex-
tracellular redox poise. This has to embrace cell membrane
behavior and an interorgan communication system that con-
nects the various contributing elements and provides a read-
out of the global redox poise. Extracellular fluids such as
interstitial fluid, lymph, and blood are especially well suited
as the connecting medium (36). We propose that the entirety
of protein thiols serves as an important redox buffer and that
extracellular thiol status helps to mark the global redox state
in health and disease.
Quantifying oxidative stress: early attempts
In vitro, oxidative stress is typically assessed by deter-
mining the concentration of reduced/oxidized glutathione,
antioxidant enzyme (SOD, catalase, glutathione peroxidase)
activity, and/or the levels of (anti)oxidants and the potential
for free radical scavenging using fluorescent molecules, with
all their limitations (205) including their lack of specificity






















































for ROS versus RSS (47). More often than not, little dis-
tinction is made between assessing capacity to cope with an
oxidant burden, determining the magnitude of exposure to
an oxidant, and the balance between exposure and anti-
oxidant capacity. Earlier attempts at quantifying oxidative
stress in vivo by measuring levels of select products of
lipid, protein, or DNA oxidation (e.g., 8-isoprostanes, mal-
ondialdehyde, protein carbonyls, 8-hydroxyguanosine) often
met with disappointment, in that all these biomarkers showed
distinct profile scaling with oxidative stress burden, but
considerable temporal heterogeneity. The reason for this di-
vergence is not immediately apparent and is likely due to the
fact that some markers are only bystanders of oxidative
damage, while others are actual regulatory nodes of the an-
tioxidant network. Insights into the systems architecture of
the redox network and its modus operandi are required to
interpret this information. Valuable insight might be derived
from information about metabolic fluxes (the direction of
travel within metabolic pathways), which can be achieved
by either applying stable isotope labeling methodology or
monitoring natural isotopic fractionation using high-sensitivity,
high-resolution mass spectrometry (fluxomics).
Assessment of low-molecular-weight and protein
thiols in plasma/serum
Based upon the assumption that thiols play a determinant
role in redox regulation, measuring the ratio of reduced over
oxidized forms of small aminothiols such as cysteine or
glutathione is potentially more powerful than measuring
levels of individual oxidation products inasmuch as it informs
us about the status of a dynamic system that serves to shuttle
nutrients between cells/organs and electrons between the
intracellular and extracellular milieu. Often misunderstood, it
is not the electrochemical redox potentials (of e.g., GSH/
GSSG) that drive the biology; those concentration ratios are
simply the outcome of fast enzymatic processes related to
thiol transport, degradation, and regeneration (57). The ratios
of reduced/oxidized thiols show diurnal variation (12) and
decrease with age, but the redox couples of cysteine and
glutathione, for example, are not in equilibrium (92). This
indicates that ratios are maintained at defined levels, which
might be presumed to confer benefits that are as yet unclear.
However, even those measurements reflect only a small part
of the overall thiol redox network as it fails to capture the
large protein-bound thiol pool (196) and kinetically con-
trolled exchange reactions with free thiols in the intra- and
extracellular compartments (Fig. 5). While the overall com-
plexity of this system has been appreciated already some time
ago (196), little is known about central regulatory nodes
governing these equilibria.
A recent report suggests that cysteine and glutathione re-
dox status are associated with mortality from coronary artery
disease (143). Another highly significant association was
found between total free thiol status in serum and clinical
outcome in unrelated clinical conditions (61, 105). Given the
overall complexity of the extracellular antioxidant network
and its link to intracellular redox status, the latter was utterly
unexpected. A simplistic view of total free thiol levels in a
given compartment could be interpreted as a direct reflection
of the balance between oxidants and antioxidant capacity (or
overall redox poise). Indeed, a decrease of reduced thiols or
an increase of oxidized thiols has been found in patients
with blood disorders, cancer, cardiovascular disease, diabe-
tes, inflammatory disease, kidney disease, metabolic disease,
neurological disease, skin disease, and thyroid disease (3,
108, 110, 123, 133, 180, 220). Thiol oxidation has also been
associated with risk factors, including aging, smoking, obe-
sity, and alcohol abuse (69). Both within cells (75) and in
blood (195), proteins constitute by far the largest pool of
redox-active thiols. Approximately 60% of the total thiol
groups in serum/plasma are accounted for by the single free
cysteine (Cys34) of albumin (195). Thus, when instead of the
ratio of free and oxidized thiols only free thiols are measured,
adjustment for total serum protein can be seen as an indirect
way of accounting for total thiol content.
In renal transplant recipients, protein-adjusted serum-free
thiols were found to predict graft failure and patient survival
(61, 105). In a small cohort of stable chronic heart failure
patients, there was a positive association between protein-
adjusted serum-free thiols and a favorable disease outcome
(61, 105). Interestingly, a study evaluating the concentra-
tion of serum protein thiols in a wide range of species con-
cluded that free thiol levels are positively associated with
life span, suggesting that control of redox status has retained
its importance from evolution to modern-day (patho)physi-
ology (146).
Studies relating serum-free thiol levels to other compo-
nents of the redox network are lacking. In this context, dis-
entangling the relationship between overall thiol redox status
(free reduced and oxidized, as well as protein-bound thiols),
which is likely affected by cellular uptake and reduction
processes, and production/metabolism of both NO and H2S/
sulfide would seem to be important. We here propose that
protein thiols in the extracellular fluid play a fundamental
role in communication between different body compart-
ments, acting as sentinels of distant danger, transporters of
specific substrates, and as dynamic entities that reflect a
readout of global thiol redox status. Rather than relying on
the integrity of a single protein to fulfill this important
function, there is greater security with greater buffering ca-
pability, and in nature, the entire protein thiol pool may play a
role for this purpose. Nevertheless, albumin is likely to play a
more important role quantitatively simply based on its
abundance in the extracellular compartment (195) and the
extent to which it transports small aminothiols. While mixed
disulfide formation can occur nonenzymatically via attack of
reactive protein thiolates (e.g., Cys34 of albumin) at the dis-
ulfide bond of oxidized thiols, the reverse process that would
regenerate the free thiol is very slow. This implies that a
significant portion of these reactions must be controlled
through the activity of specific thiol oxidoreductases such as
glutaredoxin, protein disulfide isomerase, and thioredoxin/
thioredoxin reductase (70). Besides mixed disulfide forma-
tion (S-thiolation), other sulfhydryl modifications, including
S-nitrosylation, S-sulfuration (sulfhydration), S-oxidation,
and S-acylation (e.g., S-palmitoylation), may also revers-
ibly decrease free thiol availability, but information on the
practical relevance of these processes is limited. This may
be particularly relevant for cysteinylation and persulfi-
dation of protein thiols as micromolar concentrations of
per/polysulfides were detected in biological tissues (86) and
therefore have the potential to affect the measurement of
total free thiols.






















































Intracellular redox regulation, bioenergetics,
and intermediary metabolism
The same fundamental regulatory principles that operate in
the extracellular compartment likely apply to intracellular
redox state (Fig. 5). Much emphasis has been devoted to the
process of S-cysteinylation and S-glutathionylation (46, 66),
although other post-translational modifications may be of
similar importance. Crosstalk between cell compartments of
widely different redox status (nucleus, endoplasmic reticu-
lum, peroxisomes, and mitochondria) is of significance in this
context (30, 51, 161) since the same reactive species that
modulate mitochondrial activity and dynamics (130, 211)
may also link overall redox poise to intracellular signaling,
metabolic control, and bioenergetic status (188). Mitochon-
drial dysfunction has recently been demonstrated to remodel
one-carbon metabolism (4) and the latter is fundamental for
mammalian health and disease (50).
These regulatory principles would provide the opportunity
to prioritize options for metabolic adjustments in individual
cells in relation to the overall redox status of the organism,
which might be achieved as a consequence of exchange of
redox information across cell membranes (Fig. 5). Although
the cystine/glutamate antiporter has been implicated (34), the
elements connecting intra- and extracellular spaces to ex-
change this information are currently unknown. An effective
communication across cell membranes requires moieties
that reliably operate under widely different redox conditions,
that is, under oxidative as well as reductive stress. There are
limited choices chemically that fulfill the need of electron
exchange under those extremes, but one interesting possi-
bility may involve the persulfide/perthiyl radical couple (10).
Redox state and cell survival
Redox status is also linked to cell survival (193, 222).
Effective repair of damage is cardinal to survival and resi-
lience. DNA repair mechanisms have been studied most ex-
tensively, not least because the survival of organisms
depends on faithful transmission of genetic information from
one cell to the next (and across generations), from the level of
DNA replication over chromosomal distribution to the repair
of damage incurred. This involves surveillance systems for
FIG. 5. Thiol transport between cell organelles and exchange between the intra- and extracellular compartments. In
human plasma, aminothiols such as cysteine, homocysteine, and glutathione exist in free (reduced and oxidized) and protein-
bound form, but little is known about the dynamics of their regulation and relationship with each other. As documented for
cysteine and glutathione, aminothiols are transported across cellmembranes and exchanged between cell organelles, with specific
transporters such as the cystine (CysSSCys)/glutamate (Glu) antiporter (Xc), which plays an important role in the regulation of
cell surface redox.Continuous arrows indicate known relationships, interrupted arrows represent unknown relationships. In both
the intracellular and extracellular compartments, protein thiols represent the main pool of sulfhydryl (-SH) groups. (Note that
different font sizes in the figure denote relative concentrations and thatmixed disulfides of low-molecular-weight thiols and post-
translational thiol modifications are omitted here for the sake of simplicity.) The cytosol is considerably more reduced compared
with the extracellular space or the endoplasmic reticulum (where proper protein folding requiresmore oxidizing conditions). The
redox couples, cysteine/cystine, GSH/GSSG, and protein-bound thiols, are not in equilibriumwith each other, which suggests the
involvement of specific enzyme systems that determine the steady-state levels of these species.Maintaining disequilibria requires
energy, and energy tends to be allocated according to criteria that confer robustness of organisms along the evolutionary selection
process. First steps into the direction of decoding what determines ATP utilization hierarchies at a systems level are being taken,
but the mechanisms of regulation of systemic thiol/disulfide status remain largely obscure. Considering the inverse association of
free thiols with risk of death, a further assessment of these relationships and their significance for the cellular stress responses,
DNA repair processes, and other hard clinical endpoints seems to be justified. However, no number of observational studies will
ever be able to establish causality; this will require prospective and interventional studies.






















































structural monitoring and orchestration of the sophisticated
repair processes during normal functioning (31). Sponta-
neous DNA lesions are common events (82), and the response
to DNA damage is principally orchestrated through activa-
tion of sensors, transducers, and effectors. This allows re-
solving problems induced by physical or chemical stresses
while limiting unnecessary maintenance. Several DNA repair
enzymes, including poly-ADP-ribose polymerase, are under
redox control (3), which may provide a mechanistic expla-
nation for the observed association between plasma-free
thiols and active disease. Similar processes are at work under
conditions of strong emotional stresses, which are known to
be associated with oxidative stress, poor immune function
and health, lower telomerase activity, and telomere shorten-
ing (52). These observations are akin to what happens during
normal aging, just at a higher pace. Thus, life stresses of any
sort, perceived or real, seem to lead to accelerated (prema-
ture) aging. Since parallel monitoring of multiple stresses is
energetically costly, integrated stress sensing will be a preferred
option; bacteria realize this through distributed sensing of met-
abolic fluxes (106). A sizable portion of an organism’s energy is
spent processing sensory information (162), which enables
stress tolerance; as the ability of cells to generate adequate levels
of energy declines, housekeeping and acute repair processes
are compromised and physiological function starts failing.
Perspective: How Redox Biology and Insights
into the Regulation of the RSI May Transform
Personalized Medicine
The regulatory concepts outlined above, as viewed from
the perspective of systems biology, may provide useful
guidance in any search for prevention and treatment ap-
proaches in the emerging area of redox medicine. Based upon
the notion that (i) a set of factors plays a dominant role in
sensing environmental changes (O2, amino acid substrates
around the arginine-methionine metabolome, and its cofac-
tors), (ii) another set of factors acts as transducing elements
(cysteine-based redox relays and the dynamic interplay of
free reduced and oxidized, and protein-bound thiols), and that
(iii) there are stable end products of the RSI (S,N,O-based
stable metabolites), it is possible to create a conceptual
framework, which places the complexities of these interac-
tions into context and allows to interrogate the quality and
quantity of the balance of forces among different compo-
nents. The specificity of this approach will be guided not by
predefined levels of normality of particular readouts (as
commonly practiced in current medicine), but rather by un-
derstanding what determines the metabolic fluxes through
these pathways (Fig. 6). Due to the interacting nature of the
pattern and direction of flow through many pathways within
a complex system, the nature and outcome of these inter-
actions will differ depending upon context and circum-
stance from individual to individual. This underlies the
basis of personalized medicine and indicates the diagnostic
basis needed to develop rational therapeutic interventions
that adequately meet the individual situation (Box 7). In the
following, we will present our understanding of redox reg-
ulation in the context of health and disease and suggest
methods to interrogate the activity status of its components
and how to utilize these insights for the benefit of a per-
sonalized medicine approach.
What defines health?
Contemporary medicine still uses the same organ-based
classification system physicians developed centuries ago to
define disease symptoms. We have become better and better
at treating diseases, but not necessarily at identifying the root
cause of illness or just ‘‘feeling sick’’ (166). More often than
not, disease itself is equated with dysfunction. The converse
is our limited ability to define and measure what constitutes
health. In medical diagnostic terms, it often means staying
within perceived limits of the distribution of variations in
simple physiological readouts (such as blood pressure, heart
rate, peripheral oxygen saturation, and white blood count)
and the absence of overt signs of organ/tissue damage. Sys-
tems biology has taught us much about the emergence of
unpredicted states arising from the complex interaction of
multiple, nonlinear interconnected systems and these lessons
are now being incorporated into what constitutes systems
medicine. To this end, good health is not merely a state de-
fined by the absence of overt symptoms of disease, but in-
cludes overall mental and physical well-being and resilience
to stress. Biomarkers of good health are in short supply and
limited to a few markers of nutritional adequacy (e.g., amino
acid, protein, and micronutrient status) and perceived levels
of normality of markers associated with inflammation, oxi-
dative stress cell aging (telomere length), and DNA methyl-
ation. However, the latter two tend to differ markedly
between individuals and ethnicities and provide limited in-
formation about the origin of the problem or the reserve ca-
pacity of the regulatory systems affected. From a systems
perspective, as long as an organism is alive, one can consider
its subsystems to be functioning; however, perturbations may
force them to deviate from their normal equilibria and set-
points. If severe enough, these perturbations may become
obvious and observable as disease phenotype (e.g., elevated
blood pressure, hyperglycemia), which may be interpreted as
the price paid by the organism to stay fully operational. To
this end, accelerated aging (and aging per se) may be viewed
as a process that leads to a compromised capacity for repair
and/or adaptive change, eventually culminating in system
failure and death (217).
Personalized medicine
Personalized medicine aims at providing individually tai-
lored prevention and treatment strategies for patients. One
important driver for this development is the realization that
generic treatment approaches are not optimally addressing
patients’ needs. With an aging population and ever-rising
healthcare costs, the idea is to provide tailored solutions
matched to specific deviations from the desired equilibrium
with the aim to improve population health. In the words of
the Horizon2020 Advisory Group, personalized medicine is
a medical model using characterization of individuals’ phe-
notypes and genotypes (e.g., molecular profiling, medical
imaging, and lifestyle data) for tailoring the right therapeutic
strategy for the right person at the right time and/or to de-
termine the predisposition to disease and/or to deliver timely
and targeted prevention (see https://ec.europa.eu/research/
health/index.cfm?pg=policy&policyname=personalised). The
fascination with this concept transcends medicine as it
goes well beyond the treatment with medical products to
include a better understanding of how particular biological






















































mechanisms and interactions of our body with environmen-
tal, nutritional, and infectious stresses [known as the expo-
some (210)] affect health and disease along the life course.
How can these high expectations be fulfilled?
Targeted redox metabolomics for understanding
disease processes
Great methodological strides have been made in recent
years to capture the entirety of genetic and transcriptomic
events in an affordable manner. Beyond the use of multiple
omics techniques for deep phenotyping, however, a sound
understanding of the key drivers and mechanisms underly-
ing disease processes and resilience is required. Importantly,
the mere integration of genomics, transcriptomics, and pro-
teomics does not provide any information about enzyme
function/activity and metabolic pathways. Metabolomics,
that is, the analysis of stable products of metabolic path-
ways, may offer a deeper level of information about the
state of an organ or the entire organism and may there-
fore be a key enabling technique for personal/precision
medicine (6). Much of the recent success of metabolomic
approaches is linked to the rapid advancement in mass
spectrometry-based techniques over the last two decades,
but many technical obstacles are still to be overcome to
extend the level of coverage typical of genomic approaches
to metabolic events. Measuring the entire metabolome of
every patient may remain beyond reach for some time, but
a targeted approach covering key aspects appears realis-
tic even today.
FIG. 6. Simplified scheme visualizing the consequences of a reduced redox buffering capacity (redox reserve) due
to bioenergetic limitations. Under normal physiological conditions, extracellular redox poise is subject to diurnal
variations, fluctuating between more reducing (-) and more oxidizing (+) conditions (12). The capacity of a cell/organism
to deal with changes in reductive and oxidative load is intimately linked to mitochondrial function. Enhanced mito-
chondrial activity is associated with higher oxidative stress, which affects the redox status of the local tissue microen-
vironment, while the activity of the mitochondrial respiratory chain itself and mitochondrial intermediary metabolism are
modulated by the local and global redox status (upper cartoon). An adequate bioenergetic reserve capacity allows redox
stresses (oxidative stress induced by, for example, strenuous physical activity or reductive stress due to chronic over-
feeding) into either direction to be comfortably accommodated without incurring damage to cellular constituents (upper
panels); physiological redox fluctuations experienced in daily life situations are well within the normal buffering ca-
pacity. Mitochondrial dysfunction leads to impaired cellular bioenergetics, resulting in narrowing of a cell’s or an
organism’s ability to buffer redox stresses, inflicting damage and/or compromising adaptive capacities (middle panels),
which can result in severe impairment of redox regulatory events upon further bioenergetic challenge (lower panels).
Under these conditions, significant damage may be inflicted (shaded areas), demanding the allocation of additional
energy to cellular repair processes. According to these relationships, chronic stress triggers a vicious cycle that can lead
to a condition associated with severely limited redox reserve capacity, compromising cellular surveillance and repair
mechanisms and inviting cascading network failures. This notion is consistent with the links of AMP-activated protein
kinase and aberrant mitochondrial gene expression with cellular stress, aging/degenerative processes and immune pro-
cesses (186), molecular system energetics (159, 160) in general, and the emerging concept of bioenergetic health, where
redox biology controls the interface between bioenergetics, autophagy, and circadian control of metabolism (29, 209).
See also Box 7.






















































Despite the advancements in untargeted metabolomics to
identify and analyze complex patterns of metabolites, some
of the low-abundance, polar, or volatile metabolites still
pose analytical challenges; in particular, many of the highly
reactive species of fleeting existence, for example, H2S and
its per- and polysulfides belonging to the RSI, are currently
only reliably quantifiable after chemical trapping, provid-
ing more stable derivatives (86, 99). A disadvantage of such
approaches is that they tend to perturb natural equilibria,
not only complicating the interpretation of changes re-
corded but also introducing bias as their disappearance can
elicit adaptive reactions not normally seen under physio-
logical conditions.
What to measure where and how?
To adequately capture the substrates utilized by the RSI for
sensing and transduction processes, we propose to concen-
trate on those parts of intermediary metabolism that are
central to the regulation of redox status and production of
essential building blocks of life such as DNA/RNA, vitamins,
amino acids/proteins, and fatty acids/lipids. Emphasis should
be placed on integrative biomarkers faithfully reporting on
multiple mechanisms operating in synchrony. Circulating
homocysteine concentrations are a pertinent example as they
represent a combined readout of methionine and vitamin B6/12
availability, one-carbon metabolism (methionine recycling
and tetrahydrofolate pathways), and flux through the trans-
sulfuration pathway, an ancient pathway established almost 4
bya (208); there may well be many more among the markers
we routinely assess today. Thus, besides capturing as many
species as possible around these pathways to monitor bodily
sulfur/SAA handling and H2S production, the arginine me-
tabolome will be another sensible target to capture as it
provides insight into nitrogen handling and NO-related pro-
cesses. To describe the dynamics of the thiol regulatory
system, we suggest quantifying the entirety of free and
protein-bound thiols; differences in concentration of stable
end products of the RSI in different compartments may serve
as readouts of the sensing and adaptation system in operation.
For sulfur hydrosulfide, per- and polysulfides, thiosulfate,
and sulfate would seem to be useful readouts, complemented
by ammonium, urea, nitrite, nitrate, nitroso, and nitrosyl spe-
cies for the nitrogen products. Relevant clinically accessible
compartments to analyze include blood (plasma and cellular
components), saliva, sweat, urine, and exhaled breath.
To gain insight into the regulation of the entire system,
whole-body responses to various stressors ought to be ex-
plored first in healthy individuals subjected to, for example,
exercise versus rest, hypoxia versus normoxia, heat versus
cold, fasting versus controlled feeding, and exposure to fre-
quently prescribed or over-the-counter drugs such as anti-
inflammatories. This will form the basis for subsequent
interrogations in diseased individuals and patients on specific
drug regimens and allow disentangling the underlying redox
network architecture using specific patient cohorts. Once
we understand how the system is structured, organized, and
able to sense in a way that enables control and regulation,
Box 7. Chemical Biology of the Reactive Species Interactome:
The Long and Winding Road from Evolution to Personalized Medicine
The challenge of developing a dynamic map of redox interactions is related to placing the fundamental chemistry within
a given physiological process or disease mechanism into spatial and temporal context. Although the RSI concept begins
disentangling the fundamental interplay between the different reactive species and their biological targets, before their use
in personalized medicine, specific mechanism-based biomarker panels need to be developed. To this end, the evolutionary
origin of redox regulation, based fundamentally on the handling of various sulfur species, may provide a useful pointer
since ‘‘Nature does not waste a good chemical reaction’’.
A case in point is nitrogen fixation and nitrate/nitrite reduction to make NO. Bacteria can produce NO either via
ammonia oxidation (e.g., Nitrosomonas) or denitrification (e.g., Pseudomonas), giving rise to NO emanations from soil;
plants use NO to stimulate cyclic GMP. Nitrite reductase is a P450-like enzyme that evolved into a NO synthase (NOS)
using another source that connects important proliferative and immune responses to arginine metabolism. This evolution
helps today’s mammalian organisms regulate host defense mechanisms via modulation of mitochondrial respiration and
intermediary metabolism (affecting bioenergetics and immunometabolism).
The ultimate thermodynamic equation that connects evolution with precision medicine is that describing Gibbs free
energy: DG =DH- TDS, where the fundamental reactions of small molecules depend mostly on DH or the energy of
covalent bond making. However, in the biological context, DS means there are ever-increasing differentiated states/niches
defined by the process of evolution. Precision medicine is by definition where DH meets DS. To get there involves a series
of approximations: first, the DH of the fundamental chemical reactions (The RSI: Sensing and Transducing Elements
section); second, interaction of the reactive species metabolome with macromolecules; third, cellular compartmentali-
zation; fourth, tissue interactions; fifth, systemic physiological and inflammatory reactions; sixth, the genomic and epi-
genetic interaction with these processes; and seventh, the interaction between macroorganisms and microbiome, virome,
and exposome (210).
Thermodynamics can tell us into which direction redox reactions may proceed, but it cannot tell us anything about their
speed or indeed whether those reactions can ever be fast enough to be of biological significance. Overcoming energetic
barriers by using substrate-specific enzymatic catalysis is an important first step, but just the beginning. Redox tunes
systems through reaction rates (affecting concentrations), timing, and location—these factors provide precise targets that in
nature are exploited to improve biological fitness. The challenge is to unveil how this chemical redox biology operates in
health and disease using multibiomarker analysis (via omics) and imaging tools to determine location and timing. Such
redox mapping will hold the key to novel therapeutics.






















































we will be in a position to intervene causally to achieve
defined objectives.
Summary and Outlook: Disentangling the RSI Using
Redox Metabolomics to Enable Precision Medicine
The interactions between individual constituents of the
RSI and key biological targets of the antioxidant network are
complex. Hoping to disentangle the in vivo relationships for the
benefit of defining treatment opportunities for redox medicine
will require quantifying stable decomposition products and
downstream metabolites of RSS, RNS, and ROS interaction,
along with their substrates, in multiple biofluids, in health, and
disease. Since we are not dealing with on/off reactions, it would
be naive to expect that measuring a few biomarkers in health and
comparing themwith levels one observes in overt disease would
suffice. The perils of oversimplification are nowhere more ap-
parent than in the interpretation of circulating homocysteine
concentrations (197). To capture the dynamics of regulation,
we ought to measure the same set of readouts in healthy indi-
viduals of different sex/age under varying levels of physiological
perturbation, (sedentary/exercise, normoxia/hypoxia, starved/
fed, etc.) and compare their steady-state levels under these con-
ditionswith concentrations in sex/age-matched patients suffering
from specific diseases. By carefully matching the physiologic/
metabolic phenotypes to the profile of biochemical markers, we
should be able to learn enough to decode the underlying network
architecture. In turn, this will enable us to identify new avenues
for targeted therapeutic modulation of redox signaling. Besides
guiding pharmacological treatments, those insights may also aid
in risk-stratifying patients before undergoing major surgery,
improve recovery from critical illness or major trauma, and in-
form nutritional priorities for healthy aging.
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